1. Aventis Pharma Deutschland, Gmbh (13 from 330 patents)

2. Sanofi-a Ventis Deutschland Gmbh (2 from 1,829 patents)

1. 7763662 - Use of C2-substituted indan-1-ol systems for preparing medicaments for the prophylaxis or treatment of obesity

2. 7081467 - C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals

3. 7045649 - C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals

4. 7015208 - C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals

5. 6982353 - C2-disubstituted indan-1-ol compounds, their derivatives, processes for their preparation, and their use as pharmaceuticals

6. 6946492 - Use of C2-substituted indan-1-one systems for preparing medicaments for the treatment of obesity

7. 6919380 - Derivatives of C2-substituted indan-1-ol systems for the prophylaxis or treatment of obesity

8. 6812256 - Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity

9. 6812257 - Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity

10. 6762326 - C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals

11. 6717008 - Derivatives of C2-substituted indan-1-ol compounds, methods for their preparation and use

12. 6686397 - Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity

13. 6670401 - Polysubstituted indan-1-ol compounds, and methods for their preparation and use

14. 6667345 - Derivatives of C2-substituted indan-1-ol systems for the prophylaxis or treatment of obesity

15. 6657086 - C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals